DrugPatentWatch Database Preview
Bremelanotide acetate - Generic Drug Details
» See Plans and Pricing
What are the generic sources for bremelanotide acetate and what is the scope of freedom to operate?
Bremelanotide acetate
is the generic ingredient in one branded drug marketed by Palatin Technologies and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Bremelanotide acetate has seventy-seven patent family members in twenty-four countries.
One supplier is listed for this compound.
Summary for bremelanotide acetate
| International Patents: | 77 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| DailyMed Link: | bremelanotide acetate at DailyMed |
US Patents and Regulatory Information for bremelanotide acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for bremelanotide acetate
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2235921 | Start Trial |
| Australia | 783718 | Start Trial |
| Canada | 2573142 | Start Trial |
| Mexico | 362610 | Start Trial |
| Germany | 60019598 | Start Trial |
| Ukraine | 118656 | Start Trial |
| Japan | 2008505915 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
